Efavirenz decreases methadone blood concentrations.


Autoria(s): Marzolini C.; Troillet N.; Telenti A.; Baumann P.; Decosterd L.A.; Eap C.B.
Data(s)

2000

Identificador

http://serval.unil.ch/?id=serval:BIB_3264B6C2D4B7

isbn:0269-9370

pmid:10894303

doi:10.1097/00002030-200006160-00036

isiid:000087735700036

Idioma(s)

en

Fonte

AIDS, vol. 14, no. 9, pp. 1291-1292

Palavras-Chave #Adult; Anti-HIV Agents/therapeutic use; Benzoxazines; Drug Interactions; Female; HIV Infections/blood; HIV Infections/drug therapy; Humans; Lamivudine/therapeutic use; Methadone/blood; Methadone/pharmacokinetics; Oxazines/adverse effects; Oxazines/therapeutic use; Reverse Transcriptase Inhibitors/adverse effects; Reverse Transcriptase Inhibitors/therapeutic use; Stavudine/therapeutic use; Substance Withdrawal Syndrome
Tipo

info:eu-repo/semantics/article

article